Shray Pharma LLP
About Shray Pharma LLP
Data last updated:
Shray Pharma LLP is a limited liability partnership (LLP) based in Palghar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 July 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAQ-0576. Its GSTIN is 27ADZFS2658E1ZF (Maharashtra).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Ritesh Jain Harish and Roshan Lalchand Jain.
Its latest statement of accounts is for the year ended 31 March 2022. The registered office is at Palghar, Maharashtra.
As per the financials filed for FY 2022, the LLP reported a revenue of ₹38.71 Lakh, a decline of 64% compared to the previous year. For the same year it recorded a net profit of ₹1.06 Lakh (net margin 2.7%) and EBITDA of ₹2.01 Lakh (EBITDA margin 5.2%).
Court records list 1 case involving the LLP, including 1 filed against it; 1 case is pending.
Company details
Contact details
Shray Pharma LLP's registered office is in Palghar, Maharashtra.
- Registered AddressGala 3 1st Floor Building No.1 Shiv Industrial Complex Village Sativali Vasai Road (E, Ast), Palghar, Maharashtra, India – 401208
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Shray Pharma LLP
FY 2022 filings availableShray Pharma LLP reported revenue of ₹38.71 Lakh (down 64% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 64% in the latest year. EBITDA fell 41% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | |||
| Other Income | |||
| Total Income | |||
| Purchases and Direct Costs | |||
| Personnel Expenses | |||
| Administrative Expenses | |||
| Interest | |||
| Depreciation | |||
| Total Expenses | |||
| Profit Before Tax | |||
| Tax | |||
| Profit After Tax | ₹1.06 Lakh | ||
| Profit Transferred to Partners | |||
| Assets and Liabilities | |||
| Partners' Contribution | |||
| Reserves and Surplus | |||
| Secured Loans | |||
| Unsecured Loans | |||
| Trade Payables | |||
| Other Liabilities and Provisions | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Loans and Advances | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | 2.7% | ||
| Return on Partners' Funds | |||
| Return on Assets | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Debt to Partners' Funds | |||
| Interest Coverage | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Turnover Growth | |||
| Profit Growth | |||
To see the full financial statements and ratios of Shray Pharma LLP, buy the company report.
Designated partners of Shray Pharma LLP
Shray Pharma has 5 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritesh Jain Harish Also directs: Gold Sukh Infrastructures LLP, Gold Sukh Lifescapes LLP, Gold Sukh & Urban Height Realtors LLP and 5 more | Designated Partner | 25 Jul 2019 | 7 Years 3 Months | Current |
| Roshan Lalchand Jain Also directs: Kera Bella Fashions LLP, Exemplus Healthcare Private Limited, Ferro Strategic Solutions Private Limited and 2 more | Designated Partner | 25 Jul 2019 | 7 Years 3 Months | Current |
| Rajani Kalpesh Mehta | Designated Partner | 25 Jul 2019 | 7 Years 3 Months | Current |
| Kalpesh Bhavarlal Mehta Also directs: Hestco Healthcare Private Limited, Vitalone Pharma Private Limited | Designated Partner | 25 Jul 2019 | 7 Years 3 Months | Current |
| Kamlesh Harish Jain Also directs: Gold Sukh Infrastructures LLP, Gold Sukh Lifescapes LLP, Gold Sukh & Urban Height Realtors LLP and 5 more | Designated Partner | 25 Jul 2019 | 7 Years 3 Months | Current |
Legal cases
Shray Pharma LLP has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed against the company by Tripada Healthcare Pvt. Ltd Through Authorised Person | Pending |
To see the full case history of Shray Pharma LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shray Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shray Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ADZFS2658E1ZF | Maharashtra | Active | 16 Aug 2019 |
To see the full GST registrations and return filing status of Shray Pharma LLP, buy the company report.
Recent activity
Shray Pharma LLP has 5 designated partner changes on record since 2019: 5 appointments. The latest: Kalpesh Bhavarlal Mehta was appointed as Designated Partner on 25 Jul 2019.
Frequently asked questions
Shray Pharma is an active limited liability partnership based in Palghar, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 25 July 2019 (7+ years old) and is registered under LLPIN AAQ-0576.
Shray Pharma has 5 current designated partners:
- Ritesh Jain Harish - Designated Partner
- Roshan Lalchand Jain - Designated Partner
- Rajani Kalpesh Mehta - Designated Partner
- Kalpesh Bhavarlal Mehta - Designated Partner
- Kamlesh Harish Jain - Designated Partner
The latest financial statements of Shray Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Shray Pharma is 27ADZFS2658E1ZF, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Shray Pharma is AAQ-0576. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Shray Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Shray Pharma was incorporated on 25 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Kalpesh Bhavarlal Mehta was appointed as Designated Partner on 25 Jul 2019. Kamlesh Harish Jain was appointed as Designated Partner on 25 Jul 2019. Rajani Kalpesh Mehta was appointed as Designated Partner on 25 Jul 2019. Shray Pharma has 5 designated partner changes on record in total.
The registered office of Shray Pharma is at Gala 3 1st Floor Building No.1 Shiv Industrial Complex Village Sativali Vasai Road E, Ast, Palghar, Maharashtra, India – 401208.
Shray Pharma operates in the pharma industry, in the drug formulation and development segment.